Thomas Faunce
Cited by
Cited by
Artificial photosynthesis as a frontier technology for energy sustainability
T Faunce, S Styring, MR Wasielewski, GW Brudvig, AW Rutherford, ...
Energy & Environmental Science 6 (4), 1074-1076, 2013
Energy and environment policy case for a global project on artificial photosynthesis
T Faunce
Energy & Environmental Science 6 (3), 695-698, 2013
Uniform format for disclosure of competing interests in ICMJE journals
JM Drazen, MBVD Weyden, P Sahni, J Rosenberg, A Marusic, C Laine, ...
New England Journal of Medicine 361 (19), 1896-1897, 2009
Nanosilver and global public health: international regulatory issues
T Faunce, A Watal
Nanomedicine 5 (4), 617-632, 2010
Three Australian whistleblowing sagas: lessons for internal and external regulation
TA Faunce, SNC Bolsin
Medical Journal of Australia 181 (1), 44-47, 2004
Practical virtue ethics: healthcare whistleblowing and portable digital technology
S Bolsin, T Faunce, J Oakley
Journal of medical ethics 31 (10), 612-618, 2005
Will international human rights subsume medical ethics? Intersections in the UNESCO Universal Bioethics Declaration
TA Faunce
Journal of medical ethics 31 (3), 173-178, 2005
Globalization and social determinants of health: Promoting health equity in global governance (part 3 of 3)
R Labonté, T Schrecker
Globalization and health 3 (1), 1-15, 2007
Decision-analytical modelling in health-care economic evaluations
X Sun, T Faunce
The European Journal of Health Economics 9 (4), 313-323, 2008
Violence in health care: the contribution of the Australian Patient Safety Foundation to incident monitoring and analysis
K Benveniste, P Hibbert, W Runciman
Australasian Med Publ Co Ltd, 2005
Supporting whistleblowers in academic medicine: training and respecting the courage of professional conscience
T Faunce, S Bolsin, WP Chan
Journal of Medical Ethics 30 (1), 40-43, 2004
Sunscreen safety: the precautionary principle, the Australian therapeutic goods administration and nanoparticles in sunscreens
T Faunce, K Murray, H Nasu, D Bowman
NanoEthics 2 (3), 231-240, 2008
Integrated research into the nanoparticle–protein corona: a new focus for safe, sustainable and equitable development of nanomedicines
TA Faunce, J White, KI Matthaei
Future Medicine Ltd 3 (6), 859-866, 2008
'Linkage'pharmaceutical evergreening in Canada and Australia
TA Faunce, J Lexchin
Australia and New Zealand Health Policy 4 (1), 1-11, 2007
Australian law dictionary
L Abbott, J Anderson, DK Anton, K Baker, J Barnes, G Barton, TG Beale, ...
Oxford University Press, 2010
Will the Australia-United States free trade agreement undermine the pharmaceutical benefits scheme?
K Harvey, B Lokuge, P Drahos, T Faunce
Australasian Medical Association, 2004
Flexner's ethical oversight reprised? Contemporary medical education and the health impacts of corporate globalisation
TA Faunce, P Gatenby
Medical education 39 (10), 1066-1074, 2005
The effects of restricting publicly subsidised temazepam capsules on benzodiazepine use among injecting drug users in Australia
CL Breen, LJ Degenhardt, AD Roxburgh, RB Bruno, R Jenkinson
Medical journal of Australia 181 (6), 300-304, 2004
Assessing the impact of the Australia-United States Free Trade Agreement on Australian and global medicines policy
T Faunce, E Doran, D Henry, P Drahos, A Searles, B Pekarsky, W Neville
Globalization and Health 1 (1), 1-10, 2005
Pharmaceuticals, intellectual property and free trade: the case of the US–Australia Free Trade Agreement
P Drahos, B Lokuge, T Faunce, M Goddard, D Henry
Prometheus 22 (3), 243-257, 2004
The system can't perform the operation now. Try again later.
Articles 1–20